Seuraa
Pascal Lapierre
Pascal Lapierre
Research Associate, CHUM Research Center
Vahvistettu sähköpostiosoite verkkotunnuksessa ssss.gouv.qc.ca
Nimike
Viittaukset
Viittaukset
Vuosi
Medical aspects of ketone body metabolism.
GA Mitchell, S Kassovska-Bratinova, Y Boukaftane, MF Robert, SP Wang, ...
Clinical and investigative medicine. Medecine clinique et experimentale 18 …, 1995
3371995
Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis
P Lapierre, O Hajoui, JC Homberg, F Alvarez
Gastroenterology 116 (3), 643-649, 1999
2571999
A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens
P Lapierre, I Djilali‐Saiah, S Vitozzi, F Alvarez
Hepatology 39 (4), 1066-1074, 2004
1732004
Chronic hepatitis E infection in children with liver transplantation
U Halac, K Béland, P Lapierre, N Patey, P Ward, J Brassard, A Houde, ...
Gut 61 (4), 597-603, 2012
1392012
Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance
P Lapierre, K Béland, R Yang, F Alvarez
Hepatology 57 (1), 217-227, 2013
1242013
A novel “humanized mouse” model for autoimmune hepatitis and the association of gut microbiota with liver inflammation
M Yuksel, Y Wang, N Tai, J Peng, J Guo, K Beland, P Lapierre, C David, ...
Hepatology 62 (5), 1536-1550, 2015
1132015
Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein
M Troesch, I Meunier, P Lapierre, N Lapointe, F Alvarez, M Boucher, ...
Virology 352 (2), 357-367, 2006
1032006
Influence of genes, sex, age and environment on the onset of autoimmune hepatitis
K Béland, P Lapierre, F Alvarez
World journal of gastroenterology: WJG 15 (9), 1025, 2009
862009
Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment
S Cassim, VA Raymond, L Dehbidi-Assadzadeh, P Lapierre, M Bilodeau
Cell cycle 17 (7), 903-916, 2018
852018
Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant
U Halac, K Béland, P Lapierre, N Patey, P Ward, J Brassard, A Houde, ...
The Journal of pediatrics 160 (5), 871-874. e1, 2012
852012
Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis
P Lapierre, K Béland, F Alvarez
Translational Research 149 (3), 107-113, 2007
812007
LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?
G Marceau, P Lapierre, K Béland, H Soudeyns, F Alvarez
Hepatology 42 (3), 675-682, 2005
792005
DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis
I Djilali-Saiah, P Lapierre, S Vittozi, F Alvarez
The Journal of Immunology 169 (9), 4889-4896, 2002
712002
Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development
P Lapierre, K Béland, I Djilali-Saiah, F Alvarez
Journal of autoimmunity 26 (2), 82-89, 2006
632006
From in vivo to in vitro: Major metabolic alterations take place in hepatocytes during and following isolation
S Cassim, VA Raymond, P Lapierre, M Bilodeau
PLoS One 12 (12), e0190366, 2017
622017
Transient complement inhibition promotes a tumor-specific immune response through the implication of natural killer cells
V Janelle, MP Langlois, E Tarrab, P Lapierre, L Poliquin, A Lamarre
Cancer immunology research 2 (3), 200-206, 2014
562014
Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis
S Vitozzi, I Djilali-Saiah, P Lapierre, F Alvarez
Autoimmunity 35 (8), 485-492, 2002
552002
Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis
P Lapierre, K Béland, C Martin, F Alvarez Jr, F Alvarez
Hepatology 51 (5), 1789-1798, 2010
512010
Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma
S Cassim, VA Raymond, B Lacoste, P Lapierre, M Bilodeau
Oncotarget 9 (42), 26868, 2018
502018
Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein
S Vitozzi, P Lapierre, I Djilali-Saiah, F Alvarez
Journal of immunological methods 262 (1-2), 103-110, 2002
472002
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20